Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News from Cancer Research UK

00:09 EST 18th January 2019 | BioPortfolio

Here are the most relevant search results for "Cancer Research UK" found in our extensive news archives from over 250 global news sources.

More Information about Cancer Research UK on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Cancer Research UK for you to read. Along with our medical data and news we also list Cancer Research UK Clinical Trials, which are updated daily. BioPortfolio also has a large database of Cancer Research UK Companies for you to search.

Showing News Articles 1–25 of 426 from Cancer Research UK

Monday 14th January 2019

Our milestones: Europe’s search for an anti-cancer diet

Science blog This entry is part of 30 in the series Our milestones In this instalment, we look at how our researchers helped answer the question “can diet affect someone’s risk of cancer?”. “Europe seeks a winning diet” hit the front cover of New Scientist in November 1991, announcing the start of an ambitious diet study. Diet was a hot topic in the early 90s. And many thought what ...

Saturday 12th January 2019

News digest – NHS long-term plan, chemo ‘sponge’, NHS waiting times and high fibre diets

Science blog NHS launches long-term plan with a focus on prevention The new NHS 10-year plan could save up to 500,000 lives by focusing on prevention and early detection, reports BBC News. We blogged about the announcement, which includes important commitments on cancer, including early diagnosis, more support for smokers and offering genetic testing to all children with cancer. But while the p...

Wednesday 9th January 2019

Cancer Research UK, NIHR and Athenex to trial innovative oral chemotherapy

Press release An experimental chemotherapy drug that can be taken orally is moving into early phase clinical trials as part of a new partnership between Athenex, Cancer Research UK’s Combinations Alliance and the NIHR Clinical Research Network Industry Alliance, announced today (Thursday). "This exciting partnership will enable us to accelerate the development of a treatment that not only has...

Monday 7th January 2019

NHS 10-year plan: clear commitments for cancer, but no long-term fix for staff shortages

Science blog When the Prime Minister announced £20.5bn of extra funding for the NHS in the summer, she asked the health service to produce a long-term plan for how the money would be spent in England. Today that plan has been published. It includes important commitments on cancer, such as diagnosing more cancers at an early stage, more support for smokers to quit and offering genetic testing t...

Cancer Research UK cautiously optimistic over the NHS England Long Term Plan

Press release Cancer Research UK welcomes the long term NHS plan, which reiterates the Prime Minister’s ambition to improve cancer survival for patients. More people are being diagnosed with and treated for cancer than ever before, and survival is improving. The intention to improve early diagnosis is vital if patients are to have even greater chances of surviving cancer. The plan also pledge...

Saturday 5th January 2019

News digest – a cancer breath test, tumour VR, lab culture and 2019 predictions

Science blog A cancer breath test trial launches The launch of a trial we’re supporting for a potential cancer breath test in people was widely reported. The device uses Breath Biopsy® technology that analyses the presence and quantity of chemicals in breath. Researchers based at a hospital in Cambridg

Wednesday 2nd January 2019

A breath test with the goal of detecting multiple cancers is ready to start trials

Science blog The warning signs for cancer can be vague. When people go to their GP with symptoms like heartburn or indigestion, it’s hard to say during their first appointment if cancer is to blame or if, most often, it’s something far less serious. At the moment, being offered a simple test that points either way, or flags those who need to go to a specialist for further tests, isn’t pos...

Our top researchers share their ambitions for 2019

Science blog We asked some of our top researchers to share their personal ambitions for 2019 and the key trends that they hope to see emerge in their field. Professor Karen Vousden – Cancer Research UK’s chief scientist  Professor Karen Vousden has spent the last 30 years in cancer research studying one of the most important molecules in cancer, called p53. She was director of our Beatson...

Saturday 22nd December 2018

News digest – unhealthy food tax, NICE decisions, fertility and an experimental cervical cancer test

Science blog Relapse tests for breast cancer reviewed According to the Mirror, experts have said that some women are receiving chemotherapy unnecessarily for breast cancer. The report linked this to women not being offered a test that predicts the risk of their cancer coming back after treatment. A few days later, the National Institute for Health and Care Excellence (NICE) published updated re...

Thursday 20th December 2018

Three breast cancer relapse tests recommended for NHS use

News report Three tests designed to predict if breast cancer will come back after treatment have been recommended for use on the NHS.  The tests could help women with breast cancer and their doctors to decide whether to have chemotherapy after surgery.   In its updated guidelines, the National Institute of Health and Care Excellence (NICE) has recommended the tests are offered to women wi

Targeted drug not approved for certain lymphoma patients on the NHS

News report People with a certain type of lymphoma will not be able to receive a targeted cancer drug on the NHS in England. The National Institute for Health and Care Excellence (NICE) concluded that giving brentuximab vedotin (Adcetris) to people with a type of lymphoma after they’ve had another treatment is not cost effective. The decision will be reviewed in February.  This draft guidan...

Wednesday 19th December 2018

Celebrating a lifetime in cancer biology, an early diagnosis champion, and our leaders of tomorrow: the 2018 CRUK Research Prizes

Research Feature   Our annual Research Prizes recognise the achievements of the rising stars in cancer research and celebrate the researchers who have shown outstanding dedication to beating cancer. In November, we returned to the NCRI Conference in Glasgow to award our prizes for the ninth year. Our leaders of tomorrow: the Future Leaders Prize The Future Leaders in Cancer Research Prize re...

Immune cells cast DNA ‘webs’ that may help ovarian cancer spread

News report Scientists have discovered that immune cells play a role in helping ovarian cancer cells spread in mice. Researchers from the University of Texas found that ovarian cancer cells spread to new tissue in mice after being caught in DNA webs released by specialised immune cells, called neutrophils.  Professor Victoria Sanz-Moreno, a cancer biology expert at Barts Cancer Institute says ...

Too soon to say cervical cancer DNA test will ‘revolutionise screening’

Science blog Cervical cancer screening is in the news, with some headlines saying that a new test can detect the disease 100% of the time and could ‘revolutionise screening’. But while the test itself could provide a new option for detecting changes to cells in the cervix, the reality is the test is a long way from being routinely used. And based on the research published so far, it’s no...

Tuesday 18th December 2018

6 tweets that defined cancer policy in 2018

Monday 17th December 2018

Our 5 biggest cancer research stories from 2018

Science blog It’s been another busy year in cancer research. From taking important steps towards tackling the most aggressive cancers to making treatments kinder for children, these are our 5 biggest research stories from 2018. 1. A spotlight on brain tumours Brain tumours have been hard to treat for too long, with only 1 in 7 people surviving their disease for a decade or longer. That’s wh...

Saturday 15th December 2018

News digest – specialist prostate cancer scans, HPV vaccine catch up, breast cancer risk and surgery gel spray 

Science blog Specialist prostate cancer MRI scans recommended on NHS A type of specialist MRI scan has been recommended as one of the first tests for diagnosing people with suspected prostate cancer. Studies have found that using mpMRI could help 1 in 4 men with an abnormal PSA test or rectal exam avoid a biopsy. And for those who did need a biopsy, the scan can help to guide the procedure, m...

Friday 14th December 2018

Brain Tumour Awards: Announcing our shortlist

Research Feature We've shortlisted 8 multidisciplinary teams for our £10 million Brain Tumour Awards. Meet the contenders who want to transform our understanding of these cancers and the outlook for patients.  In May, we launched a call to fund the boldest, most innovative projects in brain tumour research. Our Brain Tumour Awards, in partnership with The Brain Tumour Charity, will provide...

The new Cancer Drugs Fund has quietly reached a significant milestone

Science blog This week, the National Institute for Health and Care Excellence (NICE) finished its review of a thyroid cancer drug called vandetanib (Caprelsa). This is business as usual for NICE, which decides whether the NHS should pay for new cancer medicines in England. NICE has completed 36 of these reviews for cancer drugs (or combinations of cancer drugs) this year alone. In this case, NI...

Thursday 13th December 2018

Specialist MRI scans recommended to help diagnose prostate cancer on NHS

News report A type of specialist MRI scan has been recommended as one of the first tests for diagnosing people with suspected prostate cancer by the National Institute for Health and Care Excellence (NICE).  Right now, men with suspected prostate cancer are offered a blood test that looks for raised levels of a molecule called prostate specific antigen (PSA). Men with raised PSA levels will be...

Immunotherapy combo not approved for advanced kidney cancer patients on the NHS

News report People with a certain type of advanced kidney cancer will not be able to have a combination of two immunotherapy drugs on the NHS in England. The National Institute for Health and Care Excellence (NICE) concluded that giving the immunotherapy drugs, called ipilimumab (Yervoy) and nivolumab (Opdivo), to people with advanc

Wednesday 12th December 2018

Liverpool scientists awarded £2.17 million by Cancer Research UK to spot pancreatic cancer early

Press release Scientists in Liverpool have been awarded £2.17 million by Cancer Research UK to develop ways to spot pancreatic cancer earlier. “Sadly pancreatic cancer survival rates remain low and so more research – like the work being announced by Cancer Research UK today in Liverpool – is vital." - Peter Breaden. Pancreatic cancer survival remains very low, with only 5 to 7 out of eve...

Monday 10th December 2018

Cancer Research UK and AstraZeneca launch world class functional genomics centre

Press release Cancer Research UK and AstraZeneca have announced today that they are opening a new centre in the UK, dedicated to realising the full potential of functional genomics in the discovery and development of new drugs for patients with cancer.  “This new

Saturday 8th December 2018

News digest – lung cancer screening study, 100,000 genomes sequenced, NHS proton beam therapy and a ‘universal cancer blood test’

Science blog Major lung cancer screening study to launch Sky News reports that the UK’s largest lung cancer screening trial is launching in London. In a

Thursday 6th December 2018

Lung cancer screening part 2: research into detection technology could lead to better tests

Science blog If lung cancers are found at an early stage, the chance of treating them successfully is higher. In part one of this series, we discussed clinical trials that have tested if CT scans could be used for lung screening. In part two, we investigate re


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks